The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

ARIXIL vet 5 mg film-coated tablet for dogs and cats

5 mg/tablet Film-coated tablet

Vetpharma Animal Health, S.L.VPA10516/020/001

Main Information

Trade NameARIXIL vet 5 mg film-coated tablet for dogs and cats
Active SubstancesBenazepril hydochloride
Strength5 mg/tablet
Dosage FormFilm-coated tablet
Licence HolderVetpharma Animal Health, S.L.
Licence NumberVPA10516/020/001

Group Information

ATC CodeQC09AA07 benazepril
Therapeutic ClassCardiovascular


Licence Issued05/04/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back